TRANSLATE

The pso Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the pso Hub cannot guarantee the accuracy of translated content. The pso and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB: For educational content and news updates.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

How can adherence to treatment be improved in patients with psoriasis and PsA?

By Ella Dixon

Share:

Featured:

Ulrich MrowietzUlrich MrowietzLaura CoatesLaura CoatesAlice GottliebAlice GottliebAndré CarvalhoAndré CarvalhoJoseph MerolaJoseph Merola

Feb 7, 2024

Learning objective: After reading this article, learners will be able to cite a new development in psoriasis and psoriatic arthritis.


During the Psoriasis Hub Steering Committee Meeting in November 2023, key opinion leaders met to discuss adherence to treatment in patients with psoriasis and PsA.

How can adherence to treatment be improved in patients with psoriasis and PsA?

The recorded discussion was chaired by Paolo Gisondi and featured Alice Gottlieb, André Carvalho, Joseph Merola, Laura Coates, and Ulrich Mrowietz. The steering committee discussed why adherence may be lower with certain treatment options and how it can vary across regions. The experts also spoke about difficulties that patients face during treatment and how this impacts adherence.